JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (2006) 36 261-277    DOI: 10.1677/jme.1.02001
© 2006 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wöltje, M.
Right arrow Articles by Jahnen-Dechent, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wöltje, M.
Right arrow Articles by Jahnen-Dechent, W.

CCAAT enhancer binding protein ß and hepatocyte nuclear factor 3ß are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression

Michael Wöltje, Beate Tschöke, Verena von Bülow, Ralf Westenfeld1, Bernd Denecke, Steffen Gräber and Willi Jahnen-Dechent

Interdisciplinary Center for Clinical Research (IZKF) ‘BIOMAT’, RWTH Aachen University Hospital, Pauwelsstr. 30, D-52074 Aachen, Germany
1 Division of Nephrology and Immunology, RWTH Aachen University Hospital, Pauwelsstr. 30, D-52074 Aachen, Germany

(Requests for offprints should be addressed to M Wöltje; Email: woeltje{at}rwth-aachen.de)

Alpha2HS-glycoprotein/fetuin-A (Ahsg) is a serum protein preventing soft tissue calcification. In trauma and inflammation, Ahsg is down-regulated and therefore considered a negative acute phase protein. Enhancement of Ahsg expression as a protective serum protein is desirable in several diseases including tissue remodelling after trauma and infection, kidney and heart failure, and cancer. Using reporter gene assays in hepatoma cells combined with electrophoretic mobility shift assays we determined that dexamethasone up-regulates hepatic Ahsg. A steroid response unit at position –146/–119 within the mouse Ahsg promoter mediates the glucocorticoid-induced increase of Ahsg mRNA. It binds the hepatocyte nuclear factor 3ß and CCAAT enhancer binding protein ß (C/EBP-ß). The up-regulation is mediated indirectly via glucocorticoid hormone-induced transcriptional up-regulation in C/EBP-ß protein. A high degree of sequence identity in mouse, rat and human Ahsg promoters suggests that the promoter is similarly up-regulated by dexamethasone in all three species. Therefore, our findings suggest that glucocorticoids may be used to enhance the level of Ahsg protein circulating in serum.




This article has been cited by other articles:


Home page
HypertensionHome page
J.-S. Shao, S.-L. Cheng, J. Sadhu, and D. A. Towler
Inflammation and the Osteogenic Regulation of Vascular Calcification: A Review and Perspective
Hypertension, March 1, 2010; 55(3): 579 - 592.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Sai, C. L. Esteves, V. Kelly, Z. Michailidou, K. Anderson, A. P. Coll, Y. Nakagawa, T. Ohzeki, J. R. Seckl, and K. E. Chapman
Glucocorticoid Regulation of the Promoter of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Is Indirect and Requires CCAAT/Enhancer-Binding Protein-{beta}
Mol. Endocrinol., September 1, 2008; 22(9): 2049 - 2060.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Heiss, T. Eckert, A. Aretz, W. Richtering, W. van Dorp, C. Schafer, and W. Jahnen-Dechent
Hierarchical Role of Fetuin-A and Acidic Serum Proteins in the Formation and Stabilization of Calcium Phosphate Particles
J. Biol. Chem., May 23, 2008; 283(21): 14815 - 14825.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
V. Petrik, S. Saadoun, A. Loosemore, J. Hobbs, K. S. Opstad, J. Sheldon, E. Tarelli, F. A. Howe, B. A. Bell, and M. C. Papadopoulos
Serum {alpha}2-HS Glycoprotein Predicts Survival in Patients with Glioblastoma
Clin. Chem., April 1, 2008; 54(4): 713 - 722.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
Z. Yang, C. Guo, P. Zhu, W. Li, L. Myatt, and K. Sun
Role of glucocorticoid receptor and CCAAT/enhancer-binding protein {alpha} in the feed-forward induction of 11{beta}-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts
J. Endocrinol., November 1, 2007; 195(2): 241 - 253.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.